Calcium لـ High Blood Pressure (Hypertension)
C الأدلة أدلة محدودة من دراسات صغيرة، غير أن ثمة بعض الإشارات الإيجابية.Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'heartcited.com';
const params = 'ingredient\u003Dcalcium\u0026condition\u003Dhigh\u002Dblood\u002Dpressure';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
الخلاصة
Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
Key Study Findings
Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None
مقابل: Standard care or placebo
Outcome: Global cognition in stroke survivors
التأثير: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins)
0.009 (protein); 0.02 (B-vit)
المجتمع المدروس: Adult stroke survivors (20 trials + 14 observational)
Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily
مقابل: Placebo
Outcome: Preeclampsia risk reduction
التأثير: ~50% risk reduction
None
المجتمع المدروس: Pregnant women with low calcium intake
Review
Novel pharmacologic approaches in resistant hypertension.
Dose: Spironolactone, sacubitril/valsartan, SGLT2i
مقابل: None
Outcome: Blood pressure control in resistant HTN
التأثير: None
None
المجتمع المدروس: Patients with resistant hypertension
Review
Vegan Diet Health Benefits in Metabolic Syndrome.
Dose: None
مقابل: None
Outcome: None
التأثير: None
None
المجتمع المدروس: Adults with metabolic syndrome
cross-sectional observational study
n=260
Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
Dose: None
مقابل: Placebo
التأثير: None
None
Observational Study
n=40
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Dose: anti-digoxin antibodies (Fab)
مقابل: pre-treatment
Outcome: serum digoxin and clinical outcomes
التأثير: Fab bound digoxin; no improved clinical outcomes
None
المجتمع المدروس: Chronic digoxin toxicity patients
Key Statistics
13
الدراسات
1500
المشاركون
↔
Mixed
C
التقييم
Referenced Papers
Hypertension research : …
2025
10 اقتباسات
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Meta-Analysis
Advances in nutrition …
2025
1 اقتباسات
Wiadomosci lekarskie (Warsaw, …
2024
Nutrients
2021
113 اقتباسات
Journal of renal …
2017
26 اقتباسات
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Observational
Clinical toxicology (Philadelphia, …
2016
25 اقتباسات
Trends in cardiovascular …
2016
19 اقتباسات
Nephro-urology monthly
2014
43 اقتباسات
Zhongguo Zhong yao …
2014
4 اقتباسات
British journal of …
2013
156 اقتباسات
Acta medica Indonesiana
2007
4 اقتباسات
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
الجرعات الشائعة
- note:
- Prefer dietary sources; limit supplements to 500 mg/dose
- general:
- 1,000-1,200 mg/day from diet plus supplements
الحد الأعلى: 2,000-2,500 mg/day (total from diet and supplements)
الجرعات المدروسة في الأبحاث
| الجرعة | المدة | التأثير | ن |
|---|---|---|---|
| None | -- | Mixed | -- |
| 500 mg daily | -- | Positive | -- |
| Spironolactone, sacubitril/valsartan, SGLT2i | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Neutral | 260 |
| anti-digoxin antibodies (Fab) | -- | Neutral | 40 |
| None | -- | Mixed | -- |
| None | -- | Neutral | 2991 |
أفضل وقت للتناول: Divide doses (500 mg max per dose); carbonate with meals; citrate any time
Safety & Side Effects
الآثار الجانبية المُبلّغ عنها
- ⚠ Constipation (especially carbonate form)
- ⚠ Potential increased MI risk with high-dose supplements (controversial)
- ⚠ Kidney stones at excessive doses
- ⚠ Gas, bloating
التفاعلات المعروفة
- ● Thyroid medications (separate by 4 hours)
- ● Bisphosphonates (separate by 30-60 minutes)
- ● Iron supplements (reduced absorption — separate by 2 hours)
- ● Certain antibiotics (reduced absorption)
- ● Vitamin K2 (may help direct supplemental calcium to bones, not arteries)
الحد الأقصى المسموح به: 2,000-2,500 mg/day (total from diet and supplements)
استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
Frequently Asked Questions
Does Calcium help with High Blood Pressure (Hypertension)?
Based on 13 studies with 1,500 participants, there is limited but promising evidence that Calcium may support High Blood Pressure (Hypertension) management. Our evidence grade is C (Some Evidence).
How much Calcium should I take for High Blood Pressure (Hypertension)?
Studies have used various dosages. A commonly studied range is Prefer dietary sources; limit supplements to 500 mg/dose. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Calcium?
Reported side effects may include Constipation (especially carbonate form), Potential increased MI risk with high-dose supplements (controversial), Kidney stones at excessive doses, Gas, bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Calcium and High Blood Pressure (Hypertension)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 13 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.
Related Evidence
مكونات أخرى لـ High Blood Pressure (Hypertension)
References
- [1] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
- [2] Sasan Amanat et al.. Adv Nutr. 2025. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis. doi:10.1016/j.advnut.2025.100440 PubMed
- [3] Jerzy Głuszek. Wiad Lek. 2024. Novel pharmacologic approaches in resistant hypertension. doi:10.36740/WLek/194090 PubMed
- [4] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
- [5] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
- [6] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
- [7] Alfonso Eirin et al.. Trends Cardiovasc Med. 2016. Emerging concepts for patients with treatment-resistant hypertension. doi:10.1016/j.tcm.2016.05.004 PubMed
- [8] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
- [9] Jian-hong Li et al.. Zhongguo Zhong Yao Za Zhi. 2014. [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. PubMed
- [10] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
- [11] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.